Cleveland v. Ludwig Institute for Cancer Research Ltd.

CourtDistrict Court, S.D. California
DecidedJanuary 7, 2022
Docket3:21-cv-00871
StatusUnknown

This text of Cleveland v. Ludwig Institute for Cancer Research Ltd. (Cleveland v. Ludwig Institute for Cancer Research Ltd.) is published on Counsel Stack Legal Research, covering District Court, S.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cleveland v. Ludwig Institute for Cancer Research Ltd., (S.D. Cal. 2022).

Opinion

1 2

8 UNITED STATES DISTRICT COURT 9 SOUTHERN DISTRICT OF CALIFORNIA 10 11 DON CLEVLAND, et al., Case No.: 21cv871 JM (JLB) 12 Plaintiffs, ORDER ON MOTION TO DISMISS 13 v.

14 LUDWIG INSTITUTE FOR CANCER RESEARCH LTD., 15 16 Defendant. 17

18 19 Presently before the court is the Motion to Dismiss under Federal Rule of Civil 20 Procedure 12(b)(6) filed by Defendant Ludwig Institute for Cancer Research Ltd. (Doc. 21 No. 14). Pursuant to Local Rule 7.1(d)(1), the court finds the matters presented 22 appropriate for resolution without oral argument. Having considered the Parties’ 23 arguments, the evidence, and the law, the court rules as follows. 24 /// 25 /// 26 /// 27 /// 28 /// 1 BACKGROUND 2 I. Factual Background1 3 The instant case arises from Defendant’s employment of Plaintiffs Don Cleveland, 4 Arshad Desai, Richard Kolodner, Paul Mischel, Karen Oegema, and Bing Ren at 5 Defendant’s research branch (“San Diego Branch”) at the University of California, San 6 Diego (“UCSD”) and Defendant’s subsequent decision to close this branch. 7 A. Defendant’s Affiliation Agreement with UCSD 8 In 1991, Defendant entered into an Affiliation Agreement with UCSD to establish a 9 research branch. (Doc. No. 1 (“Compl.”) at ¶ 17). The Affiliation Agreement required 10 Defendant to appoint a Branch Director and select employees for the “continuous, active 11 conduct of medical research.” Id. at ¶¶ 17, 19-20. 12 B. Plaintiffs’ Employment 13 According to the Complaint, Plaintiffs are “leading scientists who have committed 14 their research programs to pursuing breakthroughs in cancer prevention and control.” 15 Id. at ¶ 1. Between 1996 and 2016, Plaintiffs each accepted written offers from 16 Defendant to establish laboratories at Defendant’s San Diego Branch (“Laboratory 17 Support Agreements”). Id. at ¶¶ 7-13, 22. The Laboratory Support Agreements 18 promised Plaintiffs an annual budget that would include Plaintiffs’ salaries, benefits, and 19 funding for Plaintiffs’ research. Id. at ¶ 22. Defendant also agreed to pay Plaintiffs at 20 UCSD’s salary scale. Id. at ¶ 23. In addition, Plaintiffs separately entered into 21 employment contracts with Defendant, under which Plaintiffs were appointed as 22 Defendant’s “Members” for a rolling term of five years. Id. at ¶ 25. 23 /// 24 /// 25 26 1 The Factual Background is derived from Plaintiffs’ Complaint. In a Motion to Dismiss, 27 “[a]ll allegations of material fact are taken as true and construed in the light most favorable to the nonmoving party.” Thompson v. Davis, 295 F.3d 890, 895 (9th Cir. 28 1 C. Decision to Close San Diego Branch 2 In a board meeting held on April 2018, Defendant made the decision to close the 3 San Diego Branch by December 31, 2023. Id. at ¶¶ 3, 29. On or about May 21, 2018, 4 Defendant sent letters to Plaintiffs informing them their rolling five-year employment 5 terms were being converted into four or five year fixed terms, such that each Plaintiff 6 would be terminated prior to the San Diego Branch’s closure date. Id. at ¶ 31. Defendant 7 also unilaterally imposed a multi-year budget that was allegedly insufficient to provide 8 adequate funding for Plaintiffs’ research. Id. at ¶ 32. 9 On February 12, 2019, at Defendant’s request, Plaintiffs (except Plaintiff Mischel) 10 attended a meeting with Defendant’s President and CEO, Edward McDermott, and 11 Defendant’s Scientific Director, Dr. Chi Van Dang. Id. at ¶¶ 5, 33. At the meeting, 12 Defendant presented Plaintiffs with the same reduced budget and made receiving this 13 reduced funding contingent upon Plaintiffs executing a Transition Agreement and 14 Release (“Transition Agreement”). Id. at ¶ 34. 15 The Transition Agreement required Plaintiffs to diligently pursue their scientific 16 research as Defendant’s employees despite the cut in research funding. Id. at ¶ 35. The 17 Transition Agreement also included a unilateral release and non-disparagement clause 18 and obligated Plaintiffs to ensure Defendant continued to receive UCSD’s cooperation. 19 Id. At the meeting, McDermott allegedly threatened “consequences” if Plaintiffs did not 20 sign the Transition Agreement. Id. at ¶ 5. None of the Plaintiffs agreed to the Transition 21 Agreement’s terms. Id. at ¶ 37. 22 After they declined, Plaintiffs allege Defendant followed through on its threats and 23 retaliated by further cutting Plaintiffs’ research budgets for 2020 and 2021. Id. at ¶ 39. 24 Beginning July 1, 2019, Defendant also refused to pay cost of living and merit increases 25 to match the UCSD salary scale. Id. at ¶ 40. 26 On October 31, 2019, Plaintiff Kolodner wrote a letter to McDermott, Notter, and 27 John Gordon, the Chair of Defendant’s Audit Committee, providing an analysis of why 28 1 the 2020-2021 budget was allegedly insufficient to meet Defendant’s legal obligations. 2 Id. at ¶ 41. Kolodner was demoted four days later. Id. 3 On November 4, 2019 and November 15, 2019, Plaintiffs were told Defendant 4 would not fund any research starting in 2020. Id. at ¶ 42. Defendant further directed 5 Plaintiffs to invalidate employment contracts for certain lab personnel. Id. at ¶ 42. On 6 May 5, 2021, Plaintiffs filed complaints with the Department of Fair Employment and 7 Housing and received right to sue letters. Id. at ¶ 43. These letters were served on 8 Defendant via certified mail on the same day they were received. Id. 9 II. Procedural Background 10 On May 5, 2021, Plaintiffs filed suit against Defendant. See Compl. Plaintiffs’ 11 Complaint asserts six causes of action arising primarily under labor and employment 12 laws. Id. Specifically, Plaintiffs assert that: Defendant retaliated against Plaintiff 13 Kolodner after Kolodner disclosed his belief Defendant’s 2020 and 2021 budget was 14 allegedly insufficient to meet Defendant’s various legal obligations (Count I); Defendant 15 retaliated against all Plaintiffs after each declined to sign the Transition Agreement 16 (Count II); age discrimination (Count III); wrongful adverse employment action in 17 violation of public policy (Count IV); failure to timely pay wages (Count V); and unfair 18 competition (Count VI). Id. at ¶¶ 44-94. 19 On July 6, 2021, Defendant filed the instant Motion to Dismiss. (Doc. No. 14). 20 Plaintiffs filed a Response (Doc. No. 15) and Defendant subsequently filed a Reply (Doc. 21 No. 16). The Motion is now fully briefed and ripe for resolution. 22 LEGAL STANDARD 23 Under Federal Rule of Civil Procedure 12(b)(6), a party may file a motion to 24 dismiss on the grounds that a complaint “fail[s] to state a claim upon which relief can be 25 granted[.]” A motion to dismiss under Federal Rule of Civil Procedure 12(b)(6) “tests 26 the legal sufficiency of a claim.” Navarro v. Block, 250 F.3d 729, 732 (9th Cir. 2001). 27 To survive a motion to dismiss under Rule 12(b)(6), “a complaint must contain 28 sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its 1 face.’” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 2 550 U.S. 544, 570 (2007)). The court “accept[s] factual allegations in the complaint as 3 true and construe[s] the pleadings in the light most favorable to the nonmoving party.” 4 Manzarek v. St. Paul Fire & Marine Ins. Co., 519 F.3d 1025, 1031 (9th Cir. 2008). On 5 the other hand, the court is “not bound to accept as true a legal conclusion couched as a 6 factual allegation.” Iqbal, 556 U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Daniels-Hall v. National Education Ass'n
629 F.3d 992 (Ninth Circuit, 2010)
United States v. Esperanza Aguilar-Aranceta
957 F.2d 18 (First Circuit, 1992)
Manzarek v. St. Paul Fire & Marine Insurance
519 F.3d 1025 (Ninth Circuit, 2008)
Tameny v. Atlantic Richfield Co.
610 P.2d 1330 (California Supreme Court, 1980)
Cel-Tech Communications, Inc. v. Los Angeles Cellular Telephone Co.
973 P.2d 527 (California Supreme Court, 1999)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
In Re Moffett
64 P.2d 1190 (California Court of Appeal, 1937)
Moss v. U.S. Secret Service
572 F.3d 962 (Ninth Circuit, 2009)
Patten v. Grant Joint Union High School District
37 Cal. Rptr. 3d 113 (California Court of Appeal, 2005)
Page v. Superior Court
31 Cal. App. 4th 1206 (California Court of Appeal, 1995)
Tietsworth v. Sears
720 F. Supp. 2d 1123 (N.D. California, 2010)
Yanowitz v. L'OREAL USA, INC.
116 P.3d 1123 (California Supreme Court, 2005)
Guz v. Bechtel National, Inc.
8 P.3d 1089 (California Supreme Court, 2000)
William Lukov v. Schindler Elevator Corp
594 F. App'x 357 (Ninth Circuit, 2015)
Shade v. Bay Counties Power Co.
92 P. 62 (California Supreme Court, 1907)
Karim Khoja v. Orexigen Therapeutics, Inc.
899 F.3d 988 (Ninth Circuit, 2018)
See's Candy Shops, Inc. v. Superior Court
210 Cal. App. 4th 889 (California Court of Appeal, 2012)
Navarro v. Block
250 F.3d 729 (Ninth Circuit, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
Cleveland v. Ludwig Institute for Cancer Research Ltd., Counsel Stack Legal Research, https://law.counselstack.com/opinion/cleveland-v-ludwig-institute-for-cancer-research-ltd-casd-2022.